rdf:type |
|
lifeskim:mentions |
umls-concept:C0023884,
umls-concept:C0027651,
umls-concept:C0178602,
umls-concept:C0205284,
umls-concept:C0301630,
umls-concept:C0460148,
umls-concept:C0521115,
umls-concept:C0678226,
umls-concept:C0729296,
umls-concept:C1268086,
umls-concept:C1522449
|
pubmed:issue |
3
|
pubmed:dateCreated |
2008-6-18
|
pubmed:abstractText |
To quantify potential benefits of CTV-to-PTV margin reduction for SBRT of liver tumours, as allowed by enhanced treatment precision.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0167-8140
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
87
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
432-8
|
pubmed:meshHeading |
|
pubmed:year |
2008
|
pubmed:articleTitle |
Simultaneous tumour dose escalation and liver sparing in Stereotactic Body Radiation Therapy (SBRT) for liver tumours due to CTV-to-PTV margin reduction.
|
pubmed:affiliation |
Department of Radiation Oncology, Erasmus MC - Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. silvia.molinelli@pv.infn.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|